Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Giuseppe Ippolito and Fabrizio Palmieri.
Connection Strength

2.825
  1. Early discharge of infectious disease patients: an opportunity or extra cost for the Italian Healthcare System? Infez Med. 2013 Dec; 21(4):270-8.
    View in: PubMed
    Score: 0.564
  2. Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital. Antibiotics (Basel). 2021 Mar 08; 10(3).
    View in: PubMed
    Score: 0.233
  3. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020; 15(12):e0244129.
    View in: PubMed
    Score: 0.230
  4. Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report. Int J Infect Dis. 2020 Aug; 97:174-176.
    View in: PubMed
    Score: 0.220
  5. Tuberculin skin test - Outdated or still useful for Latent TB infection screening? Int J Infect Dis. 2019 Mar; 80S:S20-S22.
    View in: PubMed
    Score: 0.202
  6. The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications. Int J Infect Dis. 2017 Mar; 56:45-53.
    View in: PubMed
    Score: 0.176
  7. Outcomes and Timing of Bedside Percutaneous Tracheostomy of COVID-19 Patients over a Year in the Intensive Care Unit. J Clin Med. 2021 Jul 28; 10(15).
    View in: PubMed
    Score: 0.060
  8. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection. J Transl Med. 2021 06 26; 19(1):272.
    View in: PubMed
    Score: 0.060
  9. Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia. Int J Infect Dis. 2021 Jul; 108:244-251.
    View in: PubMed
    Score: 0.059
  10. Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19. Front Pharmacol. 2021; 12:683529.
    View in: PubMed
    Score: 0.059
  11. No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison. Front Pharmacol. 2021; 12:621676.
    View in: PubMed
    Score: 0.059
  12. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S82-S87.
    View in: PubMed
    Score: 0.058
  13. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021 Apr; 105:532-539.
    View in: PubMed
    Score: 0.058
  14. Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options. Mediterr J Hematol Infect Dis. 2021; 13(1):e2021016.
    View in: PubMed
    Score: 0.058
  15. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect. 2021 04; 82(4):58-66.
    View in: PubMed
    Score: 0.058
  16. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol. 2020; 11:610300.
    View in: PubMed
    Score: 0.057
  17. An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2272-2275.
    View in: PubMed
    Score: 0.057
  18. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities. J Infect Dis. 2020 11 09; 222(11):1807-1815.
    View in: PubMed
    Score: 0.057
  19. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 10 27; 11(10):921.
    View in: PubMed
    Score: 0.057
  20. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):286.e7-286.e13.
    View in: PubMed
    Score: 0.057
  21. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. Emerg Infect Dis. 2020 11; 26(11):2709-2712.
    View in: PubMed
    Score: 0.056
  22. National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep. 2020 Feb 25; 12(1):8543.
    View in: PubMed
    Score: 0.054
  23. Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection. Sci Rep. 2018 10 23; 8(1):15626.
    View in: PubMed
    Score: 0.049
  24. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Tuberculosis (Edinb). 2018 07; 111:147-153.
    View in: PubMed
    Score: 0.048
  25. Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy. PLoS One. 2017; 12(12):e0189425.
    View in: PubMed
    Score: 0.047
  26. Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment. Int J Mycobacteriol. 2016 Dec; 5 Suppl 1:S141-S142.
    View in: PubMed
    Score: 0.043
  27. Modulation of interferon-gamma response to QuantiFERON-TB-plus detected by enzyme-linked immunosorbent assay in patients with active and latent tuberculosis infection. Int J Mycobacteriol. 2016 Dec; 5 Suppl 1:S143-S144.
    View in: PubMed
    Score: 0.043
  28. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit. Int J Mycobacteriol. 2016 Dec; 5 Suppl 1:S25-S26.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.